Menu Back toSession-1107-Chinese-Pharma-Biotech-from-Local-to-Global-From-Strategies-to-Tactics

The 7th DIA China Annual Meeting


Session 1107 Chinese Pharma/Biotech from Local to Global: From Strategies to Tactics

Session Chair(s)

Frank  Chiu

Frank Chiu

  • General Manager
  • Boon Pharmaceutical Research, Ltd., China
Jimmy  Zhang

Jimmy Zhang

  • Vice President, Transactions Asia Pacific Innovation Center
  • Johnson & Johnson, China

GLOBAL VS LOCAL Made in China, Developing globally

Speaker(s)

Shoubai  Chao

Shoubai Chao

  • Senior Vice President
  • Astrazeneca BioVentures, China
Frank  Jiang

Frank Jiang

  • CEO
  • CStone Pharmaceuticals, China
Xueming  Qian

Xueming Qian

  • Founder, Chairman and CEO
  • MabSpace Biosciences, China
Yan  Wu

GLOBAL VS LOCAL Made in China, Developing globally

Yan Wu

  • Head, Clinical Operation and Drug Safety
  • Hutchison MediPharma, China
James D Fan, MD

Conducting the China sponsored IND clinical trials in US

James D Fan, MD

  • Medical Director, Asia Pacific Region and Japan
  • ICON Clinical Research Ltd., Singapore
Yao  Yao

Regulatory Strategic Approach to US Market for Chinese Pharmaceutical Companies

Yao Yao

  • Image Solutions Tianjin, China
Frank  Chiu

Frank Chiu

  • General Manager
  • Boon Pharmaceutical Research, Ltd., China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650